Investor AB mulls sale of Swedish Orphan -sources

LONDON/STOCKHOLM, May 8 (Reuters) – Sweden’s Investor AB and
Priveq Investment are exploring a sale or flotation of Swedish
Orphan, their jointly owned maker of drugs for rare diseases,
two people familiar with the matter said on Friday.

Leave a Reply